
|Articles|August 1, 2003
New weapons and wins in the war on fat
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
ADA 2026 data highlight pediatric outcomes and treatment satisfaction with Afrezza
2
New sunscreen ingredient clears FDA for the first time since the 1990s
3
FDA grants GEn-1123 rare disease designations for Duchenne muscular dystrophy
4
FDA accepts vedolizumab sBLA for pediatric ulcerative colitis and Crohn's disease
5



